lcar-t2c car-t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 5, 2020 (NCT04219319)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-cell surface antigen CD4Immunity, passive
CD4 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04973527 | Phase 1 | Jun 15, 2021 | Beijing Boren Hospital, GenScript |
| NCT04219319 | Phase 1 | Jan 5, 2020 | Nanjing Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Boren Hospital | Academic/Hospital | 1 | 1 | 1 | 2021 |
| GenScript | For profit | 1 | 0 | 1 | 2021 |
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1